Secondly, we conducted a comprehensive analysis of the molecular mechanisms of SD using network pharmacology, identifying key targets such as ANXA1, SOD2, HMOX1, MMP2, and XRCC6 that have not been previously reported in the context of NPC. The gene discussed is XRCC6; the disease is nasopharyngeal carcinoma.